Expert Insights Newsletter by Medical Specialty - Oncology

Photo

Precision Medicine—An Evolving Role in Oncology

Recent advances in therapeutics and diagnostics are enabling a more targeted approach to treat an increasing number of cancers. Dr. Frederick Racke, Medical Director, Hematology/Oncology and Coagulation,Quest Diagnostics, reviews the evolution of cancer treatment and the increasing role played by... Read more 

Photo

Paraneoplastic Autoantibody Syndromes—Diagnosing Neurological Disorders

Neuronal-specific autoantibodies have a variety of potential targets, and give rise to a range of dysfunctions and neurological syndromes. Diagnosing the associated syndromes can be challenging. Dr. Stanley Naides, Medical Director, Immunology R&D, Quest Diagnostics, discusses the mechanism and presentation... Read more 

Photo

Personalized Medicine in Women’s Health — How Molecular Diagnostics Enables Effective Intervention

Advances in molecular diagnostics have led to a more individualized approach to medicine in different clinical areas. Dr. Douglas Rabin, Medical Director, Women's Health, Quest Diagnostics, reviews the impact of molecular medicine on women's health and discusses how it is... Read more 

Photo

Personalized Medicine — How Genetics and Genomics are Transforming Healthcare

Personalized medicine has gained much attention following the announcement of a national initiative to fund "a new model of patient-powered research…to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best... Read more 

Photo

Vaginitis — Molecular Testing To Address Diagnostic Challenges

Vaginitis is the most common gynecologic diagnosis in the primary care setting, affecting one in three women in their lifetime, but diagnosing its cause can be challenging.1 Dr. Dale Schwab, Senior Scientific Director, Infectious Disease, Quest Diagnostics Nichols Institute and... Read more 

Photo

Cardiovascular Disease — A Comprehensive Approach to Manage the Risks of Cardiac Events

Lowering low-density lipoprotein cholesterol (LDL-C) is the primary target for cardiovascular disease (CVD) risk reduction and can significantly reduce the incidence of cardiovascular (CV) events.1 The latest guidelines, released November 2013, reiterate the need to continue to use evidence-based medicine... Read more